Patents by Inventor Jean-Yves Gillon

Jean-Yves Gillon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OXA- AND THIADIAZOLES AND THEIR USE AS METALLOPROTEINASE INHIBITORS
    Publication number: 20110086893
    Abstract: Compounds formula (IA) or (IB), wherein W represents HO(C?O)—, HONH(C?O)— or H(C?O)N(OH)—; X represents —O— or —S—; and R1, R2, and R3 are as defined in the description and claims, are inhibitors of matrix metal oproteinases, in particular MMP9 and/or MMP12.
    Type: Application
    Filed: October 7, 2010
    Publication date: April 14, 2011
    Applicants: VERNALIS (OXFORD) LTD, LABORATOIRES SERONO S.A.
    Inventors: Andrew Paul AYSCOUGH, Stephen John DAVIES, Gilles PAIN, Jean-Yves GILLON
  • Oxa-and thiadiazoles and their use as metalloproteinase inhibitors
    Publication number: 20100035943
    Abstract: Compounds formula (IA) or (IB), wherein W represents HO(C?O)—, HONH(C?O)— or H(C?O)N(OH)—; X represents —O— or —S—; and R1, R2, and R3 are as defined in the description and claims, are inhibitors of matrix metal oproteinases, in particular MMP9 and/or MMP12.
    Type: Application
    Filed: October 14, 2009
    Publication date: February 11, 2010
    Applicants: VERNALIS (OXFORD) LTD, LABORATOIRES SERONO S.A.
    Inventors: Andrew Paul Ayscough, Stephen John Davies, Gilles Pain, Jean-Yves Gillon
  • OXA- AND THIADIAZOLES AND THEIR USE AS METALLOPROTEINASE INHIBITORS
    Publication number: 20080227833
    Abstract: Compounds formula (IA) or (IB), wherein W represents HO(C?O)—, HONH(C?O)— or H(C?O)N(OH)—; X represents —O— or —S—; and R1, R2, and R3 are as defined in the description and claims, are inhibitors of matrix metal oproteinases, in particular MMP9 and/or MMP12.
    Type: Application
    Filed: February 8, 2008
    Publication date: September 18, 2008
    Applicants: VERNALIS (OXFORD) LTD, LABORATOIRES SERONO S.A.
    Inventors: Andrew Paul AYSCOUGH, Stephen John Davies, Gilles Pain, Jean-Yves Gillon
  • Oxa-and thiadiazoles and their use as metalloproteinase inhibitors
    Patent number: 7358265
    Abstract: Compounds formula (IA) or (IB), wherein W represents HO(C?O)—, HONH(C?O)— or H(C?O)N(OH)—; X represents —O— or —S—; and R1, R2, and R3 are as defined in the description and claims, are inhibitors of matrix metalloproteinases, in particular MMP9 and/or MMP12.
    Type: Grant
    Filed: February 20, 2003
    Date of Patent: April 15, 2008
    Assignees: Vernalis (R&D) Ltd, Laboratories Serono S.A.
    Inventors: Andrew Paul Ayscough, Stephen John Davies, Gilles Pain, Jean-Yves Gillon
  • Oxa-and thiadiazoles and their use as metalloproteinase inhibitors
    Publication number: 20050222189
    Abstract: Compounds formula (IA) or (IB), wherein W represents HO(C?O)—, HONH(C?O)— or H(C?O)N(OH)—; X represents —O— or —S—; and R1, R2, and R3 are as defined in the description and claims, are inhibitors of matrix metalloproteinases, in particular MMP9 and/or MMP12.
    Type: Application
    Filed: February 20, 2003
    Publication date: October 6, 2005
    Applicants: VERNALIS (OXFORD) LTD, LABORATORIES SERONO S.A.
    Inventors: Andrew Ayscough, Stephen Davies, Gilles Pain, Jean-Yves Gillon